Key Points
- Myomo insider Micah Mitchell sold 90,231 shares on May 14 at an average price of $0.86, totaling about $77,598.66. After the sale, Mitchell still held 109,478 shares, a 45.18% reduction in the position.
- Myomo’s stock was trading near $0.91 at the time of the report, with a market cap of $35.17 million. The shares have ranged from a one-year low of $0.61 to a high of $3.69.
- Analysts remain constructive on the stock, with four analysts rating Myomo a Buy and a consensus price target of $7.67. Institutional ownership is also notable, with funds holding 44.99% of the shares.
Myomo, Inc. (NYSEAMERICAN:MYO - Get Free Report) insider Micah Mitchell sold 90,231 shares of Myomo stock in a transaction that occurred on Wednesday, May 14th. The stock was sold at an average price of $0.86, for a total value of $77,598.66. Following the transaction, the insider owned 109,478 shares in the company, valued at approximately $94,151.08. The trade was a 45.18% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Myomo Stock Performance
Shares of Myomo stock opened at $0.91 on Friday. Myomo, Inc. has a one year low of $0.61 and a one year high of $3.69. The company has a market cap of $35.17 million, a price-to-earnings ratio of -2.53 and a beta of 1.39. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.93 and a current ratio of 2.73. The business's 50 day moving average price is $0.76 and its 200 day moving average price is $0.85.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of MYO. Rosalind Advisors Inc. grew its stake in Myomo by 33.0% during the 2nd quarter. Rosalind Advisors Inc. now owns 3,595,788 shares of the company's stock worth $7,767,000 after purchasing an additional 892,127 shares in the last quarter. Jefferies Financial Group Inc. purchased a new stake in shares of Myomo in the 4th quarter valued at about $641,000. Geode Capital Management LLC lifted its holdings in shares of Myomo by 160.8% in the 2nd quarter. Geode Capital Management LLC now owns 669,281 shares of the company's stock valued at $1,446,000 after purchasing an additional 412,631 shares during the last quarter. Centiva Capital LP purchased a new stake in shares of Myomo in the 3rd quarter valued at about $190,000. Finally, Prescott Group Capital Management L.L.C. purchased a new stake in shares of Myomo in the 4th quarter valued at about $169,000. 44.99% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Craig Hallum reiterated a "buy" rating on shares of Myomo in a research report on Tuesday, March 10th. Four research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Myomo has a consensus rating of "Buy" and an average price target of $7.67.
View Our Latest Stock Report on MYO
About Myomo
(
Get Free Report)
Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company's flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users' own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.
Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
